← Open Payments lookup

EMILY YODER: Open Payments

NPI 1164106084 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,861 in 106 payments from 20 companies in 2025. Trend: 2023 $147 · 2024 $627 · 2025 $1,861

Food & beverage: $1,861
CompanyPaymentsAmount
ABBVIE INC.23$364
AstraZeneca Pharmaceuticals LP16$341
Novo Nordisk Inc13$222
Otsuka America Pharmaceutical, Inc.8$151
Lilly USA, LLC9$127
Boehringer Ingelheim Pharmaceuticals, Inc.5$78
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$61
Kowa Pharmaceuticals America, Inc.4$61
Bayer Healthcare Pharmaceuticals Inc.3$58
Exact Sciences Corporation3$57

Products named: QULIPTA, REXULTI, FARXIGA, JARDIANCE, MOUNJARO, VRAYLAR, Ozempic, UBRELVY.

Industry payments across LA — which companies pay providers there.